NS2B/NS3-IN-8 (MH1) is a small molecule inhibitor targeting the Zika virus NS2B-NS3 protease. It serves as a valuable research tool for in vitro enzymatic assays and antiviral studies, aiding in the investigation of Zika virus replication and potential therapeutic strategies.